Atlas Trials

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Clinical trial NCT03400709 · COMPLETED

Trial details

NCT number
NCT03400709
Sponsor
Hospital San Juan de Dios, Santiago
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cisplatin Adverse ReactionHearing Loss Ototoxic
Start date
2015-11-01
Primary completion
2017-06-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.